Live feed
Filing
SC 13D
SC 13D0001493152-20-010298·Gene Biotherapeutics, Inc.
Schedule 13D ownership disclosure
Gene Biotherapeutics, Inc.
Security class unavailable · CUSIP: 867671041
Event date: 2020-05-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 91.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-010298
- Form type
- SC 13D
- Filer
- Gene Biotherapeutics, Inc.
- CIK
- CIK 772320
- Filed
- Jun 01, 2020
- Reporting period
- May 22, 2020
- Description
- Schedule 13D beneficial ownership